Insulin aspart, recombinant Subcutaneous and Rosuvastatin Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Rosuvastatin Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: rosuvastatin
Brand name: Crestor, Ezallor Sprinkle
Synonyms: Rosuvastatin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Rotarix
- Insulin aspart, recombinant Subcutaneous-Rotateq
- Insulin aspart, recombinant Subcutaneous-Rotavirus Oral Vaccine
- Insulin aspart, recombinant Subcutaneous-Rotavirus Vaccine
- Insulin aspart, recombinant Subcutaneous-Rotavirus Vaccine Live Oral
- Insulin aspart, recombinant Subcutaneous-Rotavirus vaccine, live
- Rosuvastatin Tablets-Insulin degludec
- Rosuvastatin Tablets-Insulin Degludec (U-100) Prefilled Pens
- Rosuvastatin Tablets-Insulin Degludec (U-100) Vials
- Rosuvastatin Tablets-Insulin Degludec (U-200) Prefilled Pens
- Rosuvastatin Tablets-Insulin degludec and liraglutide
- Rosuvastatin Tablets-Insulin degludec and liraglutide Subcutaneous